SB-815
TX · State · USA
TX
USA
● Passed
Proposed Effective Date
2025-09-01
Texas SB 815 — An Act relating to the use of certain automated systems in, and certain adverse determinations made in connection with, the health benefit claims process
TX SB 815 prohibits utilization review agents from using automated decision systems — including AI-based algorithms — to make adverse determinations (wholly or partly) regarding the medical necessity, appropriateness, or experimental/investigational status of health care services. The bill carves out administrative support and fraud-detection functions from the prohibition. It enhances adverse determination notice requirements by requiring disclosure of both a description and the source of screening criteria and review procedures used. The Texas Commissioner of Insurance may audit and inspect a utilization review agent's use of automated decision systems at any time. The law applies to utilization review conducted for health benefit plans delivered, issued, or renewed on or after January 1, 2026.
Summary

TX SB 815 prohibits utilization review agents from using automated decision systems — including AI-based algorithms — to make adverse determinations (wholly or partly) regarding the medical necessity, appropriateness, or experimental/investigational status of health care services. The bill carves out administrative support and fraud-detection functions from the prohibition. It enhances adverse determination notice requirements by requiring disclosure of both a description and the source of screening criteria and review procedures used. The Texas Commissioner of Insurance may audit and inspect a utilization review agent's use of automated decision systems at any time. The law applies to utilization review conducted for health benefit plans delivered, issued, or renewed on or after January 1, 2026.

Enforcement & Penalties
Enforcement Authority
Texas Department of Insurance, Commissioner of Insurance. The commissioner may audit and inspect at any time a utilization review agent's use of an automated decision system for utilization review. Enforcement is agency-initiated through the existing regulatory authority over utilization review agents under Chapter 4201 of the Texas Insurance Code. No private right of action is created by this Act.
Penalties
The Act does not specify independent penalty amounts or remedies. Violations are subject to the existing enforcement and penalty framework applicable to utilization review agents under Chapter 4201 of the Texas Insurance Code, which includes administrative penalties and license sanctions available to the Commissioner of Insurance.
Who Is Covered
What Is Covered
"Automated decision system" means an algorithm, including an algorithm incorporating an artificial intelligence system, that uses data-based analytics to make, suggest, or recommend certain determinations, decisions, judgments, or conclusions.
Compliance Obligations 3 obligations · click obligation ID to open requirement page
HC-01 Healthcare AI Decision Restrictions · HC-01.1 · Deployer · Healthcare
Insurance Code § 4201.156(a), (c)
Plain Language
Utilization review agents are categorically prohibited from using any automated decision system — including AI-based algorithms — to make adverse determinations in whole or in part. This means no algorithm or AI tool may serve as even a partial basis for denying, delaying, modifying, or concluding that health care services are not medically necessary, not appropriate, or experimental/investigational. The prohibition goes beyond HC-01.1's typical requirement that a human must independently affirm adverse determinations; here, automated systems may not participate in the adverse determination at all. Automated systems remain permissible for administrative support and fraud-detection functions. Applies only to utilization review conducted for health benefit plans delivered, issued, or renewed on or after January 1, 2026.
Statutory Text
(a) A utilization review agent may not use an automated decision system to make, wholly or partly, an adverse determination. (c) This section does not prohibit the use of an algorithm, artificial intelligence system, or automated decision system for administrative support or fraud-detection functions.
HC-01 Healthcare AI Decision Restrictions · HC-01.7 · Deployer · Healthcare
Insurance Code § 4201.156(b)
Plain Language
The Commissioner of Insurance has unrestricted authority to audit and inspect a utilization review agent's use of any automated decision system in the utilization review process at any time — no advance notice, scheduled cadence, or triggering event is required. This means utilization review agents must maintain their automated decision systems and associated documentation in a state of audit readiness at all times. Note that while § 4201.156(a) prohibits automated systems from making adverse determinations, this audit provision covers the use of automated systems in utilization review generally, including permissible uses such as administrative support and fraud detection.
Statutory Text
(b) The commissioner may audit and inspect at any time a utilization review agent's use of an automated decision system for utilization review.
HC-01 Healthcare AI Decision Restrictions · HC-01.8 · Deployer · Healthcare
Insurance Code § 4201.303(a)(1)-(4)
Plain Language
When issuing an adverse determination, the utilization review agent must provide notice to the enrollee that includes: (1) the principal reasons for the adverse determination, (2) the clinical basis, (3) both a description of and the source of the screening criteria and review procedures used (the amendment changes 'or' to 'and,' requiring both elements), and (4) the complaint and appeal process including the right to independent review. The bill's amendment to subdivision (3) requires that adverse determination notices now include both a description and the source of screening criteria and review procedures — previously, either a description or the source was sufficient. The addition of 'review procedures' alongside 'screening criteria' means that if any automated tools or processes were used in the review (for permissible purposes), those procedures must be described.
Statutory Text
(a) Notice of an adverse determination must include: (1) the principal reasons for the adverse determination; (2) the clinical basis for the adverse determination; (3) a description of and the source of the screening criteria and review procedures used as guidelines in making the adverse determination; and (4) a description of the procedure for the complaint and appeal process, including notice to the enrollee of the enrollee's right to appeal an adverse determination to an independent review organization and of the procedures to obtain that review.